1 Liu J, Xiao H, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science, 2005, 309: 1206
[2]
2 Liu D, Shi W, Gao G F. Poultry carrying H9N2 act as incubators for novel human avian influenza viruses. Lancet, 2014, 383: 869
[3]
3 Liu D, Shi W, Shi Y, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: Phylogenetic, structural, and coalescent analyses. Lancet, 2013, 381: 1926-1932
[4]
4 Gao G F. Influenza and the live poultry trade. Science, 2014, 344: 235
[5]
5 Wu Y, Gao G F. Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: Live free markets and human health. Sci China Life Sci, 2013, 56: 493-494
[6]
6 Shi Y, Zhang W, Wang F, et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science, 2013, 342: 243-247
[7]
7 Zhang W, Shi Y, Lu X, et al. An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level. Science, 2013, 340: 1463-1467
[8]
8 Shi Y, Wu Y, Zhang W, et al. Enabling the ‘host jump': structural determinants of receptor-binding specificity in influenza A viruses. Nat Rev Microbiol, 2014, 12: 822-831
[9]
9 Wang F, Qi J, Bi Y, et al. Adaptation of avian influenza A (H6N1) virus from avian to human receptor-binding preference. EMBO J, 2015, pii: e201590960
[10]
10 Wang M, Zhang W, Qi J, et al. Structural basis for preferential avian receptor binding by the human-infecting H10N8 avian influenza virus. Nat Commun, 2015, 6: 5600
[11]
11 Lu X, Qi J, Shi Y, et al. Structure and receptor binding specificity of the hemagglutinin H13 from avian influenza A virus H13N6. J Virol, 2013, 87: 9077-9085
[12]
12 Wu Y, Bi Y, Vavricka C J, et al. Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res, 2013, 23: 1347-1355
[13]
13 Li Q, Sun X, Li Z, et al. Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus. Proc Natl Acad Sci USA, 2012, 109: 18897-18902
[14]
14 Vavricka C J, Liu Y, Kiyota H, et al. Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors. Nat Commun, 2013, 4: 1491
[15]
15 Lu G, Hu Y, Wang Q, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature, 2013, 500: 227-231
